James Stambaugh Insider Profile
4 Followers
James Stambaugh, former VP Clinical Affairs at Intersect ENT, holds 24.00K shares in Intersect ENT (Ticker: XENT).
James Stambaugh's Trading History
You May Also Like
James Stambaugh insider profile FAQ
What is the percentage of profitable transactions made by James Stambaugh?
The percentage of profitable transactions made by James Stambaugh is 0%.
What is the average return per transaction made by James Stambaugh?
The average return per transaction made by James Stambaugh is -31.70%.
What stocks does James Stambaugh hold?
James Stambaugh holds: XENT stocks.
What was James Stambaugh’s latest transaction?
James Stambaugh’s latest transaction was an Uninformative Sell of $64.00K.
What was James Stambaugh's most profitable transaction?
James Stambaugh’s most profitable transaction was an Informative Buy of XENT stock on November 10, 2015. The return on the trade was -27.30%.
What is James Stambaugh's role in Intersect ENT?
James Stambaugh's role in Intersect ENT is VP Clinical Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
